Evidence map›Paper›PMID 41767914›Full record

ArticleBiomedical optics express2025

Advanced 3D retinal lesion segmentation using channel-spatial attention-guided multi-scale feature aggregation.

Guangming Ni, Kaizhi Cao, Xiaoyang Qin, Xinhao Zeng, Renxiong Wu, Ling Wan, Jie Zhong, Yong Liu

Abstract read
In one paragraph

Article in Biomedical optics express, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Guangming NiSchool of Optoelectronic Science and Engineering, University of Electronic Science and Technology of China, Chengdu 610054, China.ORCID https://orcid.org/0000-0002-4516-256X
Kaizhi CaoSchool of Optoelectronic Science and Engineering, University of Electronic Science and Technology of China, Chengdu 610054, China.
Xiaoyang QinSchool of Optoelectronic Science and Engineering, University of Electronic Science and Technology of China, Chengdu 610054, China.
Xinhao ZengSchool of Optoelectronic Science and Engineering, University of Electronic Science and Technology of China, Chengdu 610054, China.
Renxiong WuSchool of Optoelectronic Science and Engineering, University of Electronic Science and Technology of China, Chengdu 610054, China.
Ling WanDepartment of Ophthalmology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu 610072, China.
Jie ZhongDepartment of Ophthalmology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu 610072, China.
Yong LiuSchool of Optoelectronic Science and Engineering, University of Electronic Science and Technology of China, Chengdu 610054, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetic macular edema (DME) and age-related macular degeneration (AMD) have emerged as leading causes of vision impairment worldwide; optical coherence tomography (OCT) has proven to be a crucial diagnostic tool for these diseases, for its rapid, non-invasive high-resolution imaging of retinal structures. Further accurate assessment of lesions in retinal OCT images plays a pivotal role in the early diagnosis of DME and AMD. However, current diagnosing of AMD and DME is restricted to utilizations of OCT two-dimensional images, for crucial three-dimensional (3D) lesion information inherent in OCT 3D images cannot be effectively extracted and utilized without appropriate methods. Here, we proposed an innovative deep-learning network characterized by fusing multi-scale feature extraction-aggregation and channel-spatial joint attention for high-accuracy 3D lesion segmentations of DME and AMD. Extensive experiment results demonstrated that our proposed method has commendable 3D segmentation performances and robust generalization capabilities, probably helping to understand DME and AMD diseases better and providing great convenience for clinical diagnosis and treatment.

Identifiers

PMID41767914
PMCPMC12945491

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.